Evidence map›Paper›PMID 33790016›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

The structure of a minimum amyloid fibril core formed by necroptosis-mediating RHIM of human RIPK3.

Xialian Wu, Yeyang Ma, Kun Zhao, Jing Zhang, Yunpeng Sun, Yichen Li, Xingqi Dong, Hong Hu, Jing Liu, Jian Wang and 7 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. High-qualitySolid state nuclear magnetic resonance · 2025
    Article
  19. Intercellular propagation of RIPK1/RIPK3 amyloid fibrils.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Xialian WuSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Yeyang MaUniversity of Chinese Academy of Sciences, 100049 Beijing, China.
Kun ZhaoUniversity of Chinese Academy of Sciences, 100049 Beijing, China.
Jing ZhangSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Yunpeng SunUniversity of Chinese Academy of Sciences, 100049 Beijing, China.ORCID 0000-0001-6301-3333
Yichen LiBio-X-Renji Hospital Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
Xingqi DongSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Hong HuSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Jing LiuSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Jian WangSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.ORCID 0000-0002-6545-3663
Xia ZhangSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Bing LiSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Huayi WangSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Dan LiBio-X-Renji Hospital Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.ORCID 0000-0002-1609-1539
Bo SunSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.ORCID 0000-0002-4590-7795
Junxia LuSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China; lujx@shanghaitech.edu.cn liulab@sioc.ac.cn.ORCID 0000-0002-4270-5821
Cong LiuUniversity of Chinese Academy of Sciences, 100049 Beijing, China; lujx@shanghaitech.edu.cn liulab@sioc.ac.cn.ORCID 0000-0003-3425-6672
Chinese Academy of Sciences · CNShanghaiTech University · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Receptor-interacting protein kinases 3 (RIPK3), a central node in necroptosis, polymerizes in response to the upstream signals and then activates its downstream mediator to induce cell death. The active polymeric form of RIPK3 has been indicated as the form of amyloid fibrils assembled via its RIP homotypic interaction motif (RHIM). In this study, we combine cryogenic electron microscopy and solid-state NMR to determine the amyloid fibril structure of RIPK3 RHIM-containing C-terminal domain (CTD). The structure reveals a single protofilament composed of the RHIM domain. RHIM forms three β-strands (referred to as strands 1 through 3) folding into an S shape, a distinct fold from that in complex with RIPK1. The consensus tetrapeptide VQVG of RHIM forms strand 2, which zips up strands 1 and 3 via heterozipper-like interfaces. Notably, the RIPK3-CTD fibril, as a physiological fibril, exhibits distinctive assembly compared with pathological fibrils. It has an exceptionally small fibril core and twists in both handedness with the smallest pitch known so far. These traits may contribute to a favorable spatial arrangement of RIPK3 kinase domain for efficient phosphorylation.

Indexed as

Amino Acid MotifsAmyloidCryoelectron MicroscopyHumansNecroptosisPhosphorylationProtein DomainsReceptor-Interacting Protein Serine-Threonine KinasesAmyloidReceptor-Interacting Protein Serine-Threonine KinasesRIPK3 protein, humanamyloid fibrilCryo-EMnecroptosisssNMR

Identifiers

PMID33790016
PMCPMC8040640
OpenAlexW3150466549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.